Nifedipine-induced gingival overgrowth in rats: Brief review and experimental study

Journal of Periodontology

Volumn 69, Issue 7, 1998, Pages 765-771

  Fu, Earl ^a,g   Nieh, Shin ^b   Hsiao, Chiang Tung ^c   Hsieh, Yao Dung ^d   Wikesjö, Ulf M E ^e   Shen, E Chin ^f  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Department of Pathology ^*

^c Institute of Dental Research

^d Department of Neuro Psychiatry   (Taiwan)

^e PFIZER INC   (United States)

^f TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Animal studies; Gingival hyperplasia etiology; Nifedipine adverse effects

Indexed keywords

NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DOSE RESPONSE; GINGIVA; GINGIVA HYPERPLASIA; GINGIVA OVERGROWTH; GINGIVITIS; HISTOMETRY; MALE; NONHUMAN; PERIODONTAL LIGAMENT; RAT; TISSUE METABOLISM;

EID: 0031927723     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.7.765     Document Type: Article

References (77)

1. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA 1939;112:1244-1245.
2. Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immuno-suppressant 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2(8151):1033-1036.
3. Starzl TE, Weil R, Iwatsuki S, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980;151:17-26.
4. Ramon Y, Behar S, Kishon Y, Engelberg IS. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5: 195-206.
5. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
6. Antman EM, Stone PH, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I. Basic and clinical electrophysiologic effects. Ann Intern Med 1980; 93:875-885.
7. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19;311-314.
8. Fattore L, Stablein M, Bledfeldt G, Semla T, Moran M, Doherty-Greenberg JM. Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dentist 1991;11:107-109.
9. Steele RM, Schuna AA, Schreiber RT. Calcium antagonist-induced gingival hyperplasia. Ann Intern Med 1994;120:663-664.
10. Pernu HE, Oikarinen K, Hietanen J, Knuuttila M. Verapamil-induced gingival overgrowth: a clinical, histologic and biochemic approach. J Oral Pathol Med 1989;18:422-425.
11. Colvard MD, Bishop J, Weissman D, Gargiulo AV. Cardizem-induced gingival hyperplasia: a report of two cases. Periodont Case Reports 1986;8:67-68.
12. Lombardi T, Fiore-Donno G, Belser U, Di Felice R. Felodipine-induced gingival hyperplasia: a clinical and histologic study. J Oral Pathol Med 1991;20:89-92.
13. Giustiniani S, Della Cuna FR, Marieni M. Hyperplastic gingivitis during diltiazem therapy. Int J Cardiol 1987;15:247-249.
14. Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
15. Bowman JM, Levy BA, Grubb RV. Gingival overgrowth induced by diltiazem. A case report. Oral Surg Oral Med Oral Pathol 1988; 65:183-185.
16. Brown RS, Sein P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol 1990;70:593-596.
17. Seymour RA. Calcium channel blockers and gingival overgrowth. Br Dent J 1991;170:376-379.
18. Bencini PL, Crosti C, Sala F, et al. Gingival hyperplasia by nifedipine: report of a case. Acta Derm Venereol 1985;65:362-365.
19. Van der Wall EE, Tuinzing DB, Hes J. Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug. Oral Surg Oral Med Oral Pathol 1985;60:38-40.
20. Shaftic AA, Widdup LL, Abate MA, Jacknowitz AI. Nifedipine-induced gingival hyperplasia. Drug Intel Clin Pharm 1986;20:602-605.
21. Jones CM. Gingival hyperplasia associated with nifedipine. Br Dent J 1986;160:416-417.
22. Yusof WZW. Nifedipine-induced gingival hyperplasia. J Can Dent Assn 1989;55:389-391.
23. Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth: report of a case treated by controlling plaque. J Clin Periodontol 1992;19:12-14.
24. Bullon P, Machuca G, Martine-Sahuquillo A, Rios JV, Rojas J, Lacalle JR. Clinical assessment of gingival hyperplasia in patient treated with nifedipine. J Clin Periodontol 1994;21:256-259.
25. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia - a histochemical and ultrastructural study. J Periodontol 1985;56:211-215.
26. Heijl L, Sundin Y. Nitrendipine-induced gingival overgrowth in dogs. J Periodontol 1989;60:104-112.
27. Morisaki I, Kato K, Loyola-Rodriguez JP, Nagata T, Ishida H. Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. J Periodont Res 1993;28:396-403.
28. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol 1991; 62:30-35.
29. Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
30. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine: histopathologic findings. J Periodontol 1987;58:639-642.
31. McGaw WT, Porter H. Cyclosporine-induced gingival overgrowth: an ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
32. Willershausen-Zonnchen B, Lemmen C, Zonnchen B, Hamm G, Schumacher U. Influence of nifedipine on the metabolism of gingival fibroblasts. Biol Chem Hoppe-Seyler 1994;375:299-303.
33. Fujii A , Matsumoto H, Nakao S, Teshigawara H, Akimoto Y. Effect of calcium-channel blockers on cell proliferation. DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. Arch Oral Biol 1994;39:99-104.
34. Romanos GE, Strub JR, Bernimoulin JP. Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva. J Periodontol 1993;64:110-119.
35. Romanos GE, Schroter-Kermani C, Hinz N, Herrmann D, Strub JR, Bernimoulin JP. Extracellular matrix analysis of nifedipine-induced gingival overgrowth: immunohistochemical distribution of different collagen types as well as the glycoprotein fibronectin. J Periodont Res 1993;28:10-16.
36. Shikata H, Utsumi N, Shimojima T, Oda Y, Okada Y. Increased expression of type VI collagen genes in drug-induced gingival enlargement. FEBS 1993;334:65-68.
37. McKevitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived form clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24:66-71.
38. Ellis JS, Seymour RA, Monkman S, Idle JR. Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowth. J Periodont Res 1993;28:373-378.
39. Salo T, Oikarinen KS, Oikarinen AI. Effect of phenytoin and nifedipine on collagen gene expression in normal human gingival fibroblasts. J Oral Pathol Med 1990;19:404-407.
40. Hassell TM, Gilbert G. Phenytoin sensitivity of fibroblasts as the basis of susceptibility to gingival enlargement. Am J Pathol 1983; 112:218-223.
41. McCulloch CAG, Knowles GC. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis? J Cell Physiol 1993;155:461-471.
42. Hassell TM. Evidence for production of an inactive collagenase by fibroblasts from phenytoin-enlarged human gingivae. J Oral Pathol 1982;11:310-317.
43. Hassell TM, Romberg E, Sobhani S, Lesko L, Douglas R. Lymphocyte-mediated effects of cyclosporine on human fibroblasts. Transplant Proc 1988;20(Suppl. 3):993-1002.
44. Ishida H, Kondoh T, Kataoka M, et al. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995;66: 345-350.
45. Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990;25:25-30.
46. Veraldi S, Piferi M, Marini D. Gingival hyperplasia following nifedipine therapy (letter to the Editor). Clin Exp Dermatol 1989;14: 93.
47. Fu E, Nieh S, Chang HL, Wang SL. Dose dependent gingival overgrowth induced by cyclosporin in rats. J Periodontol 1995;66:594-598.
48. Fu E, Nieh S, Chang HL, Wang SL. Cyclosporin-induced gingival overgrowth in rats: macroscopic and microscopic observation. Int J Periodontics Restorative Dent 1996;16:279-291.
49. Nieh S, Fu E, Chang H-L, Wang S-L, Wikesjö UME. Histopathologic alterations of periodontium in cyclosporin-treated rats. Is the periodontium a target tissue for the drug? J Clin Periodontol 1996; 23:730-736.
50. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972;34:898-906.
51. King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DMA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993; 20:286-293.
52. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
53. Pernu HE, Hannele Pernu LM, Huttunen KRH, Nieminen PA, Knuuttila MLE. Gingival overgrowth among renal transplant recipients related to immuno-suppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
54. Seymour RA, Smith CG, Turnbull DN. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12:413-419.
55. Kitamura K, Morisaki I, Adachi C, Kato K, Mihara J, Sobue S, Hamada S. Gingival overgrowth induced by cyclosporin A in rats. Arch Oral Biol 1990;35:483-486.
56. Wysocki GP, Gretinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
57. Savage NW, Seymour GJ, Robinson ME Cyclosporin-A-induced gingival enlargement. A case report. J Periodontol 1987;58:475-480.
58. Butler RT, Kalkwarf KI, Kaldahl WB. Drug-induced gingival hyperplasia: Phenytoin, cyclosporin and nifedipine. J Am Dent Assoc 1987;114:56-60.
59. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Localization of gingival overgrowth in heart transplant patients undergoing cyclosporin therapy. J Periodontol 1994;65:666-670.
60. Seibel W, Yahia NA, McCleary LB, Lesko LJ, Hassell TM. Cyclosporin induced gingival overgrowth in beagle dogs. J Oral Pathol Med 1989;18:240-245.
61. Nyska A, Waner T, Lotogorski A, et al. Animal model of human disease: Oxodipine-induced gingival hyperplasia in beagle dogs. Am J Pathol 1990;137:737-739.
62. Carrel R, Ba TT, Chapman MK. Gingival aberrations in dilantin treated guinea pigs. J Pedodont 1983;7:229-240.
63. Nascimento A, Barreto RC, Bozzo L, Almeida OP. Interaction of phenytoin and inflammation induces gingival overgrowth in rats. J Periodont Res 1985;20:386-391.
64. Ryffel B, Donatsch P, Madorin M, et al. Toxicological evaluation of Cyclosporin A. Arch Toxicol 1983;53:107-141.
65. Sodek J. A comparison of the rates of synthesis and turnover of collagen and non-collagen proteins in adult rat periodontal tissues and skin using a microassay. Arch Oral Biol 1977;22:655-665.
66. Hall BK, Squier CA. Ultrastructural quantitation of connective tissue changes in phenytion-induced gingival overgrowth in the ferret. J Dent Res 1982;61:942-952.
67. Watson EL, Dowd F. Diphenylhydantoins effect of amylase release, cyclic nucleotides and ion influx in mouse parotid acini. Eur J Pharmac 1983;88:153-160.
68. 45Ca uptake and efflux. Expl Neurol 1981;74:293-298.
69. Colombani PM, Robb B, Hess AB. Cyclosporin A binding to calmodulin: a possible site of action on T-lymphocytes. Science 1985; 228:337-339.
70. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in humangingival fibroblasts in vitro. J Oral Pathol Med 1992;21:181-185.
71. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporin-A in vitro. J Periodont Res 1989; 24:314-321.
72. Narayanan, AS, Meters DF, Page RC. Regulation of collagen production in fibroblasts cultured from normal and phenytoin-induced hyperplastic human gingiva. J Periodont Res 1988;23:118-121.
73. Vernillo AT, Schwartz NB. The effects of phenytoin (5,5-diphenylhydantoin) on human gingival fibroblasts in culture. J Periodont Res 1987;22:307-312.
74. Slavin J, Taylor J. Cyclosporin. nifedipine and gingival hyperplasia (letter to the Editor). Lancet 1987;2(8561):739.
75. Bokenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994;8:181-185.
76. Feehally J, Walls J, Mistry N, et al. Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 1987;295:310.
77. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine induced gingival overgrowth. J Clin Periodontot 1993;20:37-40.